| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.042 | 0.9 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |